Frank McCormick, Chairman of Oncology at BridgeBio Pharma, Inc. (BBIO), sold 180,150 shares at $36.37 ($6.8M) on 2019-12-27, disclosed to the SEC on 2019-12-31.
Open-market sale of $6.8M BBIO by Chairman of Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.37 | 25,531 | $929K | 13.7% |
| 2 | $36.37 | 25,531 | $929K | 13.7% |
| 3 | $36.85 | 21,656 | $798K | 11.7% |
| 4 | $36.85 | 21,656 | $798K | 11.7% |
| 5 | $38.09 | 3,500 | $133K | 2.0% |
| 6 | $39.27 | 13,705 |
| $538K |
| 7.9% |
| 7 | $39.27 | 13,705 | $538K | 7.9% |
| 8 | $40.13 | 16,858 | $676K | 10.0% |
| 9 | $40.13 | 16,858 | $677K | 10.0% |
| 10 | $41.31 | 883 | $36K | 0.5% |
| 11 | $41.31 | 883 | $36K | 0.5% |
| 12 | $42.26 | 617 | $26K | 0.4% |
| 13 | $42.26 | 617 | $26K | 0.4% |
| 14 | $42.93 | 100 | $4K | 0.1% |
| 15 | $35.74 | 16,250 | $581K | 8.6% |
| 16 | $36.86 | 900 | $33K | 0.5% |
| 17 | $36.86 | 900 | $33K | 0.5% |
| Total | $37.70 avg | 180,150 | $6.8M | 100% |
| Filing → |
| BBIO | SELL | 2025-09-08 | $7.9M | — | Filing → |
| BBIO | SELL | 2025-06-26 | $4.4M | — | Filing → |
| BBIO | SELL | 2023-12-28 | $4.2M | — | Filing → |